Negative immune responses to two‐dose mRNA COVID‐19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring

Author:

Crespo Marta1ORCID,Barrilado‐Jackson Antoni2ORCID,Padilla Eduardo2,Eguía Jorge2,Echeverria‐Esnal Daniel34,Cao Higini1,Faura Anna1,Folgueiras Montserrat1,Solà‐Porta Eulàlia1,Pascual Sergi1,Barbosa Francesc1,Hurtado Sara5,Ribera Laura5,Río‐No Laura3,Pérez‐Sáez María José1ORCID,Redondo‐Pachón Dolores1,Pascual Julio16ORCID,Arias C.,Buxeda A.,Burballa C.,Bach A.,Pedreira G.,Arenas M. D.,Collado S.,Fernández Marisol,Barbero E.,Rodríguez E.,Sans L.,Márquez E.,Vázquez S.,Oliveras A.,Galcerán B.,Nuñez S.,Ribas A.,Iriarte M.,Farrera J.,Savall O.,Causadias Rosa,Muñoz José,Villegas Eduardo,Canal Mireia,Grau Santiago,Montero Milagro,Villar Judit,Días Pilar,

Affiliation:

1. Department of Nephrology Hospital del Mar Barcelona Spain

2. Laboratori de Referència de Catalunya SA Barcelona Spain

3. Pharmacy Department Hospital del Mar Barcelona Spain

4. Infectious Pathology and Antimicrobials Research Group (IPAR) Institut Hospital del Mar for Medical Research Barcelona Spain

5. Department of Nephrology Fresenius Medical Care Services Barcelona Spain

6. Department of Nephrology Hospital Universitario 12 de Octubre Madrid Spain

Funder

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference56 articles.

1. Characteristics of SARS-CoV-2 and COVID-19

2. SARS‐CoV‐2: structure, biology, and structure‐based therapeutics development;Wang MY;Front Cell Infect Microbiol,2020

3. Factors associated with COVID-19-related death using OpenSAFELY

4. Outcomes of COVID‐19 among hospitalized patients with non‐dialysis CKD;Coca A;Front Med,2020

5. Chronic kidney disease is a key risk factor for severe COVID‐19: a call to action by the ERA‐EDTA;Ortiz A;Nephrol Dial Transplant,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3